North America Neurological Biomarkers Market Analysis 2026

North America Neurological Biomarkers

North America Neurological Biomarkers Market Analysis 2026

At cognitive, a dedicated team has worked on this report. You can initiate the discussion via Book an appointment.

Author By: Anushka Gore

Our research analyst works closely with North America Neurological Biomarkers market experts to validate gathered data.

Industry Expert: Not Disclosed (NDA)

Historical data 2022–2025. Base Year: 2025. Forecast: 2026–2034.

Data Updated: March 2026

Unique identification number from Cognitive's database.

Report ID: CMR782262
Report Edition: 8th (North America: Revenue Million )
Report Pages: 250+
Rating: 4.8 | Review: 6

Athenaeum Dashboard, PDF, Excel, MS Word, Cloud Access and AI Assistant.

Format: Athenaeum Dashboard, Digital Link, PDF, EXCEL, MS Word, Cloud Access and Athenaeum AI Assistant

8th Edition published by Cognitive Market Research.

8th Edition 2026
Revenue: Million

North America Neurological Biomarkers Market Analysis 2026

2021 Market Size $2348.8 Million
2025 Market Size $3642.62 Million
2033 Forecast $8760.92 Million
CAGR 2025–2033 11.594%
Data Timeline Historical Data: 2022-2025 | Base Year: 2025 | Forecast Period: 2026-2034
Imaging techniques Segment Analysis Transcranial magnetic stimulation (TMS), Diffusion tensor imaging (DTI), Conventional structural MRI (sMRI), Functional magnetic resonance imaging (fMRI), Positron emission tomography (PET)
Application Segment Analysis Proteomics based biomarkers, Genomic based biomarkers, Imaging based biomarkers, Metabolic based biomarkers
Indication Segment Analysis Alzheimer's disease (AD), Multiple sclerosis (MS), Parkinson's disease (PD), Autism spectrum disorder (ASD)
End-user Segment Analysis Hospitals, Clinics, Diagnostic and research laboratories
Country Analysis United States, Canada, Mexico


Buy Now